ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,670Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 60

$385K Total Retail Price of All Prescriptions

Rank: 1 out of 60

260 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 260 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 7,123 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
FUROSEMIDE 463 382 1 6
OMEPRAZOLE 365 292 2 3
LEVOTHYROXINE SODIUM 324 295 3 2
SIMVASTATIN 311 266 4 1
HYDROCODONE-ACETAMINOPHEN 276 195 S3 5 5
AMLODIPINE BESYLATE 219 218 6 7
WARFARIN SODIUM 215 200 7 10
LISINOPRIL 195 183 8 4
LOVASTATIN 191 150 9 16
METOPROLOL TARTRATE 175 145 10 9
DIGOXIN 152 128 11 42
HYDROCHLOROTHIAZIDE 141 125 12 11
AZITHROMYCIN 120 99 13 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 106 13 36
METFORMIN HCL 117 103 15 8
POTASSIUM CHLORIDE 117 88 15 12
ALLOPURINOL 110 84 17 19
CITALOPRAM HBR 107 91 18 20
ZOLPIDEM TARTRATE 98 68 19 14
IBUPROFEN 96 59 20 47
LOSARTAN-HYDROCHLOROTHIAZIDE 95 80 21 60
LOSARTAN POTASSIUM 92 72 22 21
KLOR-CON 10 91 89 23 61
GABAPENTIN 90 83 24 15
ZETIA 75 55 25 69
GLIMEPIRIDE 70 51 26 46
ALENDRONATE SODIUM 68 68 27 40
SPIRIVA 67 26 28 44
NOVOLOG 65 56 29 49
CYCLOBENZAPRINE HCL 64 19 R 30 32
FAMOTIDINE 63 52 31 53
MELOXICAM 63 49 31 25
SERTRALINE HCL 62 44 33 43
ATENOLOL 60 55 34 27
NEXIUM 57 31 35 34
CLOPIDOGREL 55 53 36 13
PREDNISONE 55 36 36 26
SYNTHROID 52 39 38 35
PROAIR HFA 51 16 39 44
CARVEDILOL 50 36 40 23
FENOFIBRATE 50 25 40 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.